Silginer M - Search Results

1

CRISPR/Cas9-mediated abrogation of CD95L/CD95 signaling-induced glioma cell growth and immunosuppression increases survival in murine glioma models.

Quijano-Rubio C, Silginer M, Weller M. Quijano-Rubio C, et al. Among authors: silginer m. J Neurooncol. 2022 Nov;160(2):299-310. doi: 10.1007/s11060-022-04137-x. Epub 2022 Nov 10. J Neurooncol. 2022. PMID: 36355258 Free PMC article.

2

Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells.

Happold C, Roth P, Wick W, Schmidt N, Florea AM, Silginer M, Reifenberger G, Weller M. Happold C, et al. Among authors: silginer m. J Neurochem. 2012 Jul;122(2):444-55. doi: 10.1111/j.1471-4159.2012.07781.x. Epub 2012 May 28. J Neurochem. 2012. PMID: 22564186 Free article.

3

Integrin control of the transforming growth factor-β pathway in glioblastoma.

Roth P, Silginer M, Goodman SL, Hasenbach K, Thies S, Maurer G, Schraml P, Tabatabai G, Moch H, Tritschler I, Weller M. Roth P, et al. Among authors: silginer m. Brain. 2013 Feb;136(Pt 2):564-76. doi: 10.1093/brain/aws351. Epub 2013 Jan 31. Brain. 2013. PMID: 23378223 Free article.

4

Integrin inhibition promotes atypical anoikis in glioma cells.

Silginer M, Weller M, Ziegler U, Roth P. Silginer M, et al. Cell Death Dis. 2014 Jan 23;5(1):e1012. doi: 10.1038/cddis.2013.543. Cell Death Dis. 2014. PMID: 24457956 Free PMC article.

5

Interferon-β induces loss of spherogenicity and overcomes therapy resistance of glioblastoma stem cells.

Happold C, Roth P, Silginer M, Florea AM, Lamszus K, Frei K, Deenen R, Reifenberger G, Weller M. Happold C, et al. Among authors: silginer m. Mol Cancer Ther. 2014 Apr;13(4):948-61. doi: 10.1158/1535-7163.MCT-13-0772. Epub 2014 Feb 13. Mol Cancer Ther. 2014. PMID: 24526161 Free article.

6

The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway.

Silginer M, Burghardt I, Gramatzki D, Bunse L, Leske H, Rushing EJ, Hao N, Platten M, Weller M, Roth P. Silginer M, et al. Oncogene. 2016 Jun 23;35(25):3260-71. doi: 10.1038/onc.2015.387. Epub 2015 Oct 26. Oncogene. 2016. PMID: 26500056

7

Control of glioma cell migration and invasiveness by GDF-15.

Codó P, Weller M, Kaulich K, Schraivogel D, Silginer M, Reifenberger G, Meister G, Roth P. Codó P, et al. Among authors: silginer m. Oncotarget. 2016 Feb 16;7(7):7732-46. doi: 10.18632/oncotarget.6816. Oncotarget. 2016. PMID: 26741507 Free PMC article.

8

Biological activity of tumor-treating fields in preclinical glioma models.

Silginer M, Weller M, Stupp R, Roth P. Silginer M, et al. Cell Death Dis. 2017 Apr 20;8(4):e2753. doi: 10.1038/cddis.2017.171. Cell Death Dis. 2017. PMID: 28425987 Free PMC article.

9

Autocrine activation of the IFN signaling pathway may promote immune escape in glioblastoma.

Silginer M, Nagy S, Happold C, Schneider H, Weller M, Roth P. Silginer M, et al. Neuro Oncol. 2017 Oct 1;19(10):1338-1349. doi: 10.1093/neuonc/nox051. Neuro Oncol. 2017. PMID: 28475775 Free PMC article.

10

NKG2D-Dependent Antitumor Effects of Chemotherapy and Radiotherapy against Glioblastoma.

Weiss T, Schneider H, Silginer M, Steinle A, Pruschy M, Polić B, Weller M, Roth P. Weiss T, et al. Among authors: silginer m. Clin Cancer Res. 2018 Feb 15;24(4):882-895. doi: 10.1158/1078-0432.CCR-17-1766. Epub 2017 Nov 21. Clin Cancer Res. 2018. PMID: 29162646 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters